The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin

Arthritis and Rheumatism

Volumn 65, Issue 1, 2013, Pages 69-80

  Van Beers, Joyce J B C ^a   Schwarte, Carla M ^a   Stammen Vogelzangs, Judith ^a   Oosterink, Els ^a   Božič, Borut ^b   Pruijn, Ger J M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIBODY; BETA ACTIN; CITRULLINOME; CYCLOPHILIN A; DIFFERENTIATION ANTIGEN; FIBRINOGEN; MYELOID NUCLEAR DIFFERENTIATION ANTIGEN; POLYPEPTIDE; PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; WESTERN BLOTTING;

ACTINS; AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION; APOLIPOPROTEINS E; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOTTING, WESTERN; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; SYNOVIAL FLUID;

EID: 84871798688     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37720     Document Type: Article

References (46)

1. Van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113-21.
2. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L,. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004; 50: 3085-92.
3. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9.
4. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6.
5. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
6. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ,. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
7. Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006; 36: 2250-63.
8. Vossenaar ER, Despres N, Lapointe E, van der Heijden A, Lora M, Senshu T, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004; 6: R142-50.
9. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J Immunol 2001; 166: 4177-84.
10. Takizawa Y, Suzuki A, Sawada T, Ohsaka M, Inoue T, Yamada R, et al. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 2006; 65: 1013-20.
11. Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 2010; 62: 44-52.
12. Senshu T, Sato T, Inoue T, Akiyama K, Asaga H,. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 1992; 203: 94-100.
13. Colantonio DA, Dunkinson C, Bovenkamp DE, Van Eyk JE,. Effective removal of albumin from serum. Proteomics 2005; 5: 3831-5.
14. Frey A, Di Canzio J, Zurakowski D,. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998; 221: 35-41.
15. Van Steendam K, Tilleman K, De Ceuleneer M, De Keyser F, Elewaut D, Deforce D,. Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins. Arthritis Res Ther 2010; 12: R132.
16. Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K,. Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford) 2005; 44: 1374-82.
17. Mantle D, Falkous G, Walker D,. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999; 284: 45-58.
18. Nakano S, Ikata T, Kinoshita I, Kanematsu J, Yasuoka S,. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 1999; 17: 161-70.
19. Sinz A, Bantscheff M, Mikkat S, Ringel B, Drynda S, Kekow J, et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002; 23: 3445-56.
20. Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, et al. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Arthritis Rheum 2010; 62: 117-25.
21. El-Ghobarey A, Whaley K,. Alternative pathway complement activation in rheumatoid arthritis. J Rheumatol 1980; 7: 453-60.
22. Ciurtin C, Cojocaru VM, Miron IM, Preda F, Milicescu M, Bojinca M, et al. Correlation between different components of synovial fluid and pathogenesis of rheumatic diseases. Rom J Intern Med 2006; 44: 171-81.
23. Ananth L, Prete PE, Kashyap ML,. Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis. Metabolism 1993; 42: 803-6.
24. Kinloch A, Lundberg K, Wait R, Wegner N, Lim NH, Zendman AJ, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008; 58: 2287-95.
25. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R94.
26. Hermansson M, Artemenko K, Ossipova E, Eriksson H, Lengqvist J, Makrygiannakis D, et al. MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin Appl 2010; 4: 511-8.
27. Cirino G, Cicala C, Bucci MR, Sorrentino L, Maraganore JM, Stone SR,. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996; 183: 821-7.
28. Tabushi Y, Nakanishi T, Takeuchi T, Nakajima M, Ueda K, Kotani T, et al. Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis. Ann Clin Biochem 2008; 45: 413-7.
29. Tilleman K, Van Steendam K, Cantaert T, De Keyser F, Elewaut D, Deforce D,. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford) 2008; 47: 597-604.
30. Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006; 8: R175.
31. Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M,. Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 2002; 290: 979-83.
32. Hagiwara T, Hidaka Y, Yamada M,. Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. Biochemistry 2005; 44: 5827-34.
33. Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al. Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R1421-9.
34. Suzuki A, Yamada R, Ohtake-Yamanaka M, Okazaki Y, Sawada T, Yamamoto K,. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 2005; 333: 418-26.
35. Yoshida M, Tsuji M, Kurosaka D, Kurosaka D, Yasuda J, Ito Y, et al. Autoimmunity to citrullinated type II collagen in rheumatoid arthritis. Mod Rheumatol 2006; 16: 276-81.
36. Postigo J, Genre F, Iglesias M, Fernandez-Rey M, Buelta L, Carlos Rodriguez-Rey J, et al. Exacerbation of type II collagen- induced arthritis in apolipoprotein E-deficient mice in association with the expansion of Th1 and Th17 cells. Arthritis Rheum 2011; 63: 971-80.
37. Asquith DL, Miller AM, Hueber AJ, Liew FY, Sattar N, McInnes IB,. Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. Arthritis Rheum 2010; 62: 472-7.
38. Darrah E, Rosen A, Giles JT, Andrade F,. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012; 71: 92-8.
39. Theofilopoulos AN, Baccala R, Beutler B, Kono DH,. Type I interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 2005; 23: 307-36.
40. Mondini M, Vidali M, Airo P, De Andrea M, Riboldi P, Meroni PL, et al. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann NY Acad Sci 2007; 1110: 47-56.
41. Yang Y, Lu N, Zhou J, Chen ZN, Zhu P,. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1299-310.
42. Billich A, Winkler G, Aschauer H, Rot A, Peichl P,. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med 1997; 185: 975-80.
43. Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF, et al. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 2007; 56: 3949-52.
44. Van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 2010; 69: 1554-61.
45. Van de Stadt LA, de Koning MH, van de Stadt RJ, Wolbink G, Dijkmans BA, Hamann D, et al. Development of the anti- citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum 2011; 63: 3226-33.
46. Sokolove J, Zhao X, Chandra PE, Robinson WH,. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum 2011; 63: 53-62.